Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
Beconase Aq Generic Name & Formulations
Legal Class
Rx
General Description
Beclomethasone dipropionate 42mcg/spray; aqueous nasal spray.
Pharmacological Class
Steroid.
How Supplied
Nasal spray—25g (180 sprays)
Manufacturer
Beconase Aq Indications
Indications
Allergic and vasomotor rhinitis. Prophylaxis of nasal polyp recurrence.
Beconase Aq Dosage and Administration
Adults and Children
<6yrs: not recommended. ≥6yrs: 1–2 sprays in each nostril twice daily; max 2 sprays in each nostril twice daily. Reevaluate if no improvement in 3 weeks; nasal polyp prophylaxis may warrant longer treatment.
Beconase Aq Contraindications
Not Applicable
Beconase Aq Boxed Warnings
Not Applicable
Beconase Aq Warnings/Precautions
Warnings/Precautions
Avoid in recent nasal septal ulcers, nasal surgery, or nasal trauma until healed. Monitor periodically for possible changes in nasal mucosa with long-term use. Discontinue if persistent nasopharyngeal irritation or Candida infection (treat with local therapy) occurs. Respiratory tract tuberculosis. Untreated infections (eg, fungal, bacterial, viral, ocular herpes simplex). If exposed to chickenpox or measles, consider immune globulin or antiviral prophylactic therapies. Monitor for hypercorticism and HPA axis suppression (if occurs, discontinue gradually), growth suppression in children, or any visual changes. Avoid eyes. Pregnancy. Nursing mothers.
Beconase Aq Pharmacokinetics
See Literature
Beconase Aq Interactions
Not Applicable
Beconase Aq Adverse Reactions
Adverse Reactions
Nasal irritation, sneezing, headache, nausea, epistaxis, rhinorrhea.
Beconase Aq Clinical Trials
See Literature
Beconase Aq Note
Not Applicable
Beconase Aq Patient Counseling
See Literature
